. Author manuscript; available in PMC: 2021 Jul 30.

Published in final edited form as: Int J Tuberc Lung Dis. 2012 Apr 9;16(7):891–896. doi: 10.5588/ijtld.11.0795

Table 7.

Factors associated with favourable MDR-TB treatment outcomes among non-drinkers (n = 154) in Tomsk, Russian Federation

Characteristic	Univariable OR (95%CI)	Final model OR (95%CI
Male sex^*	0.32 (0.12–0.83)
Prior incarceration^*	0.22 (0.10–0.51)	0.34 (0.14–0.79)
Diagnosis of alcoholism	0.39 (0.10–1.49)
Smoking history^*	0.14 (0.04–0.48)	0.19 (0.05–0.71)
Baseline XDR-TB	0.25 (0.06–1.09)
Bilateral and cavitary disease at baseline	0.62 (0.28–1.35)
Adherence to 80% of doses^*	6.21 (1.64–23.51)	4.27 (1.06–17.11)
Any AEs requiring treatment interruption	2.96 (0.97–9.05)

Entered into main effects multivariable model.

MDR-TB = multidrug-resistant tuberculosis; OR = odds ratio; CI = confidence interval; XDR-TB = extensively drug-resistant tuberculosis; AEs = adverse events.